Pfizer has released its study of an oral covid treatment, which they said helps reduce the risk of severe disease and death from covid and was effective against the Omicron variant. Pfizer submitted an application asking the Food Administration to authorize the treatment last month.
Pfizer has released its study of an oral covid treatment, which they said helps reduce the risk of severe disease and death from covid and was effective against the Omicron variant. Pfizer submitted an application asking the Food Administration to authorize the treatment last month.